CDHA CAAR

September 2, 2014

CAAR – Lancet Oncology Article Abstracts – September 2, 2014

Filed under: Reports and Articles — Tags: — admin @ 4:43 pm

A. “Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial,” by Prof. Karim Fizazi, Prof. Howard I. Scher, Prof. Kurt Miller, Ethan Basch, Cora N. Sternberg, Prof. David Cella, David Forer, Mohammad Hirmand, and Prof. Johann S. de Bono (Vol. 15, No. 10, October 2014, p. 1147-1156).

www.thelancet.com/journals/lanonc/article/PIIS1470-2045(14)70303-1/abstract

B. “Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial,” by J. Athene Lane, Jenny L. Donovan, Michael Davis, Eleanor Walsh, Daniel Dedman, Liz Down, Emma L. Turner, Malcolm D. Mason, Chris Metcalfe, Tim J. Peters, David E. Neal, and Freddie C. Hamdy, for the ProtecT study group (Vol. 15, No. 10, October 2014, p. 1109-1118).

www.thelancet.com/journals/lanonc/article/PIIS1470-2045(14)70361-4/abstract

No Comments

No comments yet.

RSS feed for comments on this post.

Sorry, the comment form is closed at this time.

Powered by WordPress